Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Cellzome secures second alliance with GSK

Country: United Kingdom

Cellzome Inc said that it has secured a new drug discovery deal with GlaxoSmithKline under which the companies will seek to identify small-molecule drugs against epigenetic targets. Cellzome will receive €33 million upfront.

Read more

Novartis plans $5 billion, three-tranche bond issue

Country: Switzerland

Novartis AG is raising $5 billion with a three-tranche bond issue to finance part of its pending acquisition of Alcon Inc, a large eye-care company with sales of approximately $6.5 billion in 2009.

Read more

Therapeutic vaccine producer raises €13.1 million

Country: France

Read more

Actelion receives FDA complete response letter for Zavesca

Country: Switzerland

Read more

Ark Therapeutics drops Cerepro appeal

Country: United Kingdom

Read more

Recentin fails to meet primary endpoint in cancer trial

Country: United Kingdom

Read more

Roche and Biogen Idec suspend RA trials with ocrelizumab

Country: Switzerland

Read more

Alzheimer’s drug fails at Phase 3

Country: United States

Read more

Merck to acquire Millipore for $7.2 billion

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for medical entrepreneurs in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical.

Read more

Free Article

Major events in Oncology in 2009

Oncology in 2009.pdf